Biosimilars and drug development in allergic and immunologic diseases

J Allergy Clin Immunol. 2017 May;139(5):1461-1464. doi: 10.1016/j.jaci.2017.03.008. Epub 2017 Mar 27.
No abstract available

Keywords: Allergic; biologics.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anti-Allergic Agents / therapeutic use*
  • Antirheumatic Agents / economics
  • Antirheumatic Agents / therapeutic use*
  • Biological Products / economics
  • Biological Products / therapeutic use*
  • Biosimilar Pharmaceuticals / economics
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Drug Development*
  • Drugs, Generic / economics
  • Drugs, Generic / therapeutic use*
  • Europe / epidemiology
  • Humans
  • Hypersensitivity / drug therapy*
  • Hypersensitivity / epidemiology
  • Immune System Diseases / drug therapy*
  • Immune System Diseases / epidemiology
  • United States / epidemiology

Substances

  • Anti-Allergic Agents
  • Antirheumatic Agents
  • Biological Products
  • Biosimilar Pharmaceuticals
  • Drugs, Generic